NCT04371965View on ClinicalTrials.gov

Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

October 23, 2020

Study Completion Date

October 23, 2020

Conditions
COVID-19
Interventions
DRUG

Povidone-Iodine

Patients in the experimental group will be asked to gargle with a 1% povidone-iodine solution, spray their nose with the same antiseptic solution, and finally applied 10% povidone-iodine cream in each nostril, all four times a day for five days.

Trial Locations (1)

86021

University Hospital of Poitiers, Poitiers

All Listed Sponsors
lead

Poitiers University Hospital

OTHER

NCT04371965 - Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Naso- Pharyngeal Viral Load in Patients With COVID-19 | Biotech Hunter | Biotech Hunter